Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Medtronic
Colorcon
Mallinckrodt
Express Scripts

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Veledimex


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Veledimex?

Veledimex is an investigational drug.

There have been 8 clinical trials for Veledimex. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2013.

The most common disease conditions in clinical trials are Glioblastoma, Breast Neoplasms, and Glioma. The leading clinical trial sponsors are Ziopharm, Castle Creek Biosciences, LLC., and Fibrocell Technologies, Inc.

There are twenty-four US patents protecting this investigational drug and two hundred and thirty-one international patents.

Recent Clinical Trials for Veledimex
TitleSponsorPhase
A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)Castle Creek Biosciences, LLC.Phase 1/Phase 2
A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)Fibrocell Technologies, Inc.Phase 1/Phase 2
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive GlioblastomaZiopharmPhase 2

See all Veledimex clinical trials

Clinical Trial Summary for Veledimex

Top disease conditions for Veledimex
Top clinical trial sponsors for Veledimex

See all Veledimex clinical trials

US Patents for Veledimex

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Veledimex ⤷  Try it Free Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof Intrexon Corporation (Blacksburg, VA) ⤷  Try it Free
Veledimex ⤷  Try it Free Boron-containing diacylhydrazines INTREXON CORPORATION (Blacksburg, VA) ⤷  Try it Free
Veledimex ⤷  Try it Free Crystalline diacylhydrazine and the use thereof INTREXON CORPORATION (Blacksburg, VA) ⤷  Try it Free
Veledimex ⤷  Try it Free Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof Intrexon Corporation (Blacksburg, VA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Veledimex

Drugname Country Document Number Estimated Expiration Related US Patent
Veledimex Australia AU2008307643 2027-09-28 ⤷  Try it Free
Veledimex Brazil BRPI0817233 2027-09-28 ⤷  Try it Free
Veledimex Canada CA2715080 2027-09-28 ⤷  Try it Free
Veledimex China CN101868241 2027-09-28 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Medtronic
Colorcon
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.